Crossmark Global Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Crossmark Global Holdings’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,720	Closed	-$200K	–	1287
2024 Q3	$200K	Buy	+4,720	New	+$200K	﹤0.01%	1245
2023 Q3	–	Sell	-5,754	Closed	-$205K	–	1313
2023 Q2	$205K	Sell	5,754 -73	-1%	-$2.35K	﹤0.01%	1248
2023 Q1	$237K	Buy	5,827 +391	+7%	+$16.2K	0.01%	1154
2022 Q4	$245K	Sell	5,436 -397	-7%	-$18K	0.01%	1100
2022 Q3	$279K	Sell	5,833 -67	-1%	-$3.67K	0.01%	1023
2022 Q2	$350K	Sell	5,900 -130	-2%	-$10.7K	0.01%	965
2022 Q1	$701K	Buy	6,030 +80	+1%	+$9.34K	0.02%	766
2021 Q4	$896K	Buy	5,950 +4,210	+242%	+$568K	0.02%	661
2021 Q3	$208K	Buy	+1,740	New	+$192K	﹤0.01%	1336

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crossmark Global Holdings's TNDM Position: Q4 2024 in Review

Crossmark Global Holdings sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 4,720 shares — an estimated $200K sold.

Crossmark Global Holdings first reported a position in TNDM in Q3 2021 and held it in 9 quarters. The position peaked at $896K in Q4 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

Crossmark Global Holdings reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
Crossmark Global Holdings sold 4,720 Tandem Diabetes Care shares in Q4 2024, an estimated $200K.
Crossmark Global Holdings first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 9 quarters.
Crossmark Global Holdings's Tandem Diabetes Care position peaked at $896K in Q4 2021.
316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Crossmark Global Holdings's 13F filing for Q4 2024, filed 16 Jan 2025.